Welcome to LookChem.com Sign In|Join Free

CAS

  • or

132131-24-9

Post Buying Request

132131-24-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

132131-24-9 Usage

Uses

2-Amino-5-iodobenzonitrile is a useful intermediate for the synthesis of lapatinib intermediate of N-[3-chloro-4-3-fluorophenzyloxyphenyl]-6-iodoquinazolin-4-amine.

Check Digit Verification of cas no

The CAS Registry Mumber 132131-24-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,2,1,3 and 1 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 132131-24:
(8*1)+(7*3)+(6*2)+(5*1)+(4*3)+(3*1)+(2*2)+(1*4)=69
69 % 10 = 9
So 132131-24-9 is a valid CAS Registry Number.

132131-24-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-AMINO-5-IODOBENZONITRILE

1.2 Other means of identification

Product number -
Other names 2-cyano-4-iodoaniline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:132131-24-9 SDS

132131-24-9Synthetic route

anthranilic acid nitrile
1885-29-6

anthranilic acid nitrile

5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

Conditions
ConditionsYield
With K(ICl2) In methanol; water at 20℃; for 2h;93%
With ammonium iodide; dihydrogen peroxide; acetic acid at 20℃; for 12h;92.6%
With ammonium iodide; dihydrogen peroxide; acetic acid at 20℃; for 12h;92.6%
N-iodo-succinimide
516-12-1

N-iodo-succinimide

anthranilic acid nitrile
1885-29-6

anthranilic acid nitrile

5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

Conditions
ConditionsYield
In DMF (N,N-dimethyl-formamide) at 20℃; for 18h;73%
N-(2-cyano-4-iodo-phenyl)-2,2,2-trifluoro-acetamide

N-(2-cyano-4-iodo-phenyl)-2,2,2-trifluoro-acetamide

5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

Conditions
ConditionsYield
With potassium carbonate In methanol at 20℃; for 12h;
N-(2,4-diiodo-phenyl)-2,2,2-trifluoro-acetamide
878133-06-3

N-(2,4-diiodo-phenyl)-2,2,2-trifluoro-acetamide

5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: dimethylformamide / 0.5 h / 100 °C
2: aq. K2CO3 / methanol / 12 h / 20 °C
View Scheme
2,4-diiodoaniline
533-70-0

2,4-diiodoaniline

5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: dimethylformamide / 0.5 h / 20 °C
2: dimethylformamide / 0.5 h / 100 °C
3: aq. K2CO3 / methanol / 12 h / 20 °C
View Scheme
p-aminoiodobenzene
540-37-4

p-aminoiodobenzene

5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: ICl / dimethylformamide / 0.5 h / 20 °C
2: dimethylformamide / 0.5 h / 20 °C
3: dimethylformamide / 0.5 h / 100 °C
4: aq. K2CO3 / methanol / 12 h / 20 °C
View Scheme
anthranilic acid nitrile
1885-29-6

anthranilic acid nitrile

A

5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

B

3-iodo-2-aminobenzonitrile
114344-67-1

3-iodo-2-aminobenzonitrile

Conditions
ConditionsYield
With dihydrogen peroxide; acetic acid; potassium iodide In water at 20℃; for 24h;
Iodine monochloride
7790-99-0

Iodine monochloride

anthranilic acid nitrile
1885-29-6

anthranilic acid nitrile

5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

Conditions
ConditionsYield
In acetic acid at 25 - 35℃; for 3h;
5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

N,N-dimethyl-formamide
68-12-2, 33513-42-7

N,N-dimethyl-formamide

N’-(2-cyano-4-iodophenyl)-N,N-dimethyl formamidine
903597-10-4

N’-(2-cyano-4-iodophenyl)-N,N-dimethyl formamidine

Conditions
ConditionsYield
In N,N-dimethyl acetamide at 110℃; for 2h; Product distribution / selectivity; Heating / reflux;100%
at 70 - 75℃; for 2h;
5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

N,N-dimethyl-formamide dimethyl acetal
4637-24-5

N,N-dimethyl-formamide dimethyl acetal

(E)-N'-(2-cyano-4-iodophenyl)-N,N-dimethylformamidine

(E)-N'-(2-cyano-4-iodophenyl)-N,N-dimethylformamidine

Conditions
ConditionsYield
at 120℃; for 2h;100%
at 90℃; for 1h;98%
at 90℃; for 1h;1.2 g
5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

N,N-dimethyl-formamide dimethyl acetal
4637-24-5

N,N-dimethyl-formamide dimethyl acetal

N’-(2-cyano-4-iodophenyl)-N,N-dimethyl formamidine
903597-10-4

N’-(2-cyano-4-iodophenyl)-N,N-dimethyl formamidine

Conditions
ConditionsYield
at 120℃; for 2h;100%
at 120℃; for 2h;100%
With acetic acid In toluene at 35℃; for 0.5h;89.3%
With acetic acid at 35℃; for 0.5h;89.3%
With acetic acid In toluene at 35℃; for 0.5h;89.3%
ortho-bromophenylacetic acid
18698-97-0

ortho-bromophenylacetic acid

5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

2-(2-bromophenyl)-N-(2-cyano-4-iodophenyl)acetamide

2-(2-bromophenyl)-N-(2-cyano-4-iodophenyl)acetamide

Conditions
ConditionsYield
Stage #1: ortho-bromophenylacetic acid With thionyl chloride In dichloromethane for 4h; Reflux;
Stage #2: 5-iodoanthranilonitrile In toluene for 16h; Reflux;
99%
5-formylfurane-2-boronic acid
27329-70-0

5-formylfurane-2-boronic acid

5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

2-amino-5-[(5-formyl)furan-2-yl]benzonitrile

2-amino-5-[(5-formyl)furan-2-yl]benzonitrile

Conditions
ConditionsYield
With palladium 10% on activated carbon; triethylamine In methanol; 1,2-dimethoxyethane at 20 - 45℃; for 3h; Suzuki Coupling;98.6%
5-formylfurane-2-boronic acid
27329-70-0

5-formylfurane-2-boronic acid

toluene-4-sulfonic acid
104-15-4

toluene-4-sulfonic acid

5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

2-amino-5-[(5-formyl)furan-2-yl]benzonitrile p-toluenesulfonic acid

2-amino-5-[(5-formyl)furan-2-yl]benzonitrile p-toluenesulfonic acid

Conditions
ConditionsYield
Stage #1: 5-formylfurane-2-boronic acid; 5-iodoanthranilonitrile With palladium 10% on activated carbon; triethylamine In methanol; 1,2-dimethoxyethane at 20 - 45℃; for 3h;
Stage #2: toluene-4-sulfonic acid In water at 60℃;
96%
(E)-N'-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)formamidine

(E)-N'-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)formamidine

5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-iodoquinazolin-4-amine
231278-20-9

N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-iodoquinazolin-4-amine

Conditions
ConditionsYield
With toluene-4-sulfonic acid In toluene at 110℃; for 5h;92.2%
cyclohexanone
108-94-1

cyclohexanone

5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

9-amino-7-iodo-1,2,3,4-tetrahydroacridine
252357-65-6

9-amino-7-iodo-1,2,3,4-tetrahydroacridine

Conditions
ConditionsYield
Stage #1: cyclohexanone; 5-iodoanthranilonitrile With zinc(II) chloride at 145 - 150℃; for 0.5h; Condensation;
Stage #2: With sodium hydroxide In water at 60℃; for 1h; Hydrolysis;
91%
With sodium hydroxide; zinc(II) chloride Multistep reaction;
Stage #1: cyclohexanone; 5-iodoanthranilonitrile With zinc(II) chloride at 140℃; Condensation;
Stage #2: With sodium hydroxide Addition;
guanidine hydrochloride
50-01-1

guanidine hydrochloride

5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

2,4-diamino-6-iodoquinazoline
132131-20-5

2,4-diamino-6-iodoquinazoline

Conditions
ConditionsYield
With sodium ethanolate In ethanol at 80 - 150℃; for 26h;90%
(methoxymethylidene)dimethylammonium methyl sulfate
21511-55-7, 34643-89-5

(methoxymethylidene)dimethylammonium methyl sulfate

5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

N’-(2-cyano-4-iodophenyl)-N,N-dimethyl formamidine
903597-10-4

N’-(2-cyano-4-iodophenyl)-N,N-dimethyl formamidine

Conditions
ConditionsYield
With sodium methylate In toluene at 20℃; for 9h;86.9%
5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

N,N-dimethyl-formamide
68-12-2, 33513-42-7

N,N-dimethyl-formamide

6-Iodo-1H-quinazoline-2,4-dione
16353-27-8

6-Iodo-1H-quinazoline-2,4-dione

Conditions
ConditionsYield
With zinc(II) chloride at 200℃; for 5h; sealed tube;80%
acetic anhydride
108-24-7

acetic anhydride

5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

2-cyano-4-iodoacetanilide

2-cyano-4-iodoacetanilide

Conditions
ConditionsYield
In acetic acid Heating;79%
5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

2-cyano-4-iodobenzenediazonium tetrafluoroborate

2-cyano-4-iodobenzenediazonium tetrafluoroborate

Conditions
ConditionsYield
With tert.-butylnitrite; boron trifluoride diethyl etherate In tetrahydrofuran at -20 - 5℃; for 0.5h;77%
5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

4-bromo-benzaldehyde
1122-91-4

4-bromo-benzaldehyde

phenylboronic acid
98-80-6

phenylboronic acid

2-(4-bromophenyl)-6-iodo-4-phenylquinazoline

2-(4-bromophenyl)-6-iodo-4-phenylquinazoline

Conditions
ConditionsYield
With potassium fluoride; 5,5'-dimethyl-2,2'-bipyridine; bis(acetylacetonato)palladium(II); trifluorormethanesulfonic acid In N,N-dimethyl-formamide at 80℃; for 48h; Sealed tube; Schlenk technique;76%
(E)-N'-(1-(3-fluorobenzyl)-1H-indol-5-yl)-N,N-dimethylformamide

(E)-N'-(1-(3-fluorobenzyl)-1H-indol-5-yl)-N,N-dimethylformamide

5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

N-(1-(3-fluorobenzyl)-1H-indazol-5-yl)-6-iodoquinazolin-4-amine
231278-79-8

N-(1-(3-fluorobenzyl)-1H-indazol-5-yl)-6-iodoquinazolin-4-amine

Conditions
ConditionsYield
With acetic acid In 5,5-dimethyl-1,3-cyclohexadiene for 10h; Reflux;75.63%
4-fluoroboronic acid
1765-93-1

4-fluoroboronic acid

benzaldehyde
100-52-7

benzaldehyde

5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

4-(4-fluorophenyl)-6-iodo-2-phenylquinazoline

4-(4-fluorophenyl)-6-iodo-2-phenylquinazoline

Conditions
ConditionsYield
With potassium fluoride; 5,5'-dimethyl-2,2'-bipyridine; bis(acetylacetonato)palladium(II); trifluorormethanesulfonic acid In N,N-dimethyl-formamide at 80℃; for 48h; Sealed tube; Schlenk technique;72%
5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

bis(pinacol)diborane
73183-34-3

bis(pinacol)diborane

2‐amino‐5‐(4,4,5,5‐tetramethyl‐1,3,2‐dioxaborolan‐2‐yl)benzonitrile
934426-22-9

2‐amino‐5‐(4,4,5,5‐tetramethyl‐1,3,2‐dioxaborolan‐2‐yl)benzonitrile

Conditions
ConditionsYield
With potassium acetate; (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride In N,N-dimethyl-formamide at 80℃; for 4h;69%
With potassium acetate; dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2 In N,N-dimethyl-formamide at 80℃; for 4h;69%
benzaldehyde
100-52-7

benzaldehyde

5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

phenylboronic acid
98-80-6

phenylboronic acid

6-iodo-2,4-diphenylquinazoline

6-iodo-2,4-diphenylquinazoline

Conditions
ConditionsYield
With potassium fluoride; 5,5'-dimethyl-2,2'-bipyridine; bis(acetylacetonato)palladium(II); trifluorormethanesulfonic acid In N,N-dimethyl-formamide at 80℃; for 48h; Sealed tube; Schlenk technique;68%
4-methyl-benzaldehyde
104-87-0

4-methyl-benzaldehyde

5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

phenylboronic acid
98-80-6

phenylboronic acid

6-iodo-4-phenyl-2-(p-tolyl)quinazoline

6-iodo-4-phenyl-2-(p-tolyl)quinazoline

Conditions
ConditionsYield
With potassium fluoride; 5,5'-dimethyl-2,2'-bipyridine; bis(acetylacetonato)palladium(II); trifluorormethanesulfonic acid In N,N-dimethyl-formamide at 80℃; for 48h; Sealed tube; Schlenk technique;67%
2-(methoxycarbonyl)benzenediazonium tetrafluoroborate
342-54-1

2-(methoxycarbonyl)benzenediazonium tetrafluoroborate

5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

acetonitrile
75-05-8

acetonitrile

10-iodo-6-methyl-13H-quinazolino[3,4-a]quinazolin-13-one

10-iodo-6-methyl-13H-quinazolino[3,4-a]quinazolin-13-one

Conditions
ConditionsYield
at 80℃; for 5h; Sealed tube;66%
7-(PHENYLSULFONYL)-1H-INDOLE-2-CARBOXYLIC acid
666859-79-6

7-(PHENYLSULFONYL)-1H-INDOLE-2-CARBOXYLIC acid

5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

N-(2-CYANO-4-IODOPHENYL)-7-(PHENYLSULFONYL)-1H-INDOLE-2-carboxamide

N-(2-CYANO-4-IODOPHENYL)-7-(PHENYLSULFONYL)-1H-INDOLE-2-carboxamide

Conditions
ConditionsYield
Stage #1: 7-(PHENYLSULFONYL)-1H-INDOLE-2-CARBOXYLIC acid With oxalyl dichloride In DMF (N,N-dimethyl-formamide); dichloromethane at 20℃; for 3h;
Stage #2: 5-iodoanthranilonitrile In pyridine; dichloromethane at 20℃;
65%
4-Chlorophenylboronic acid
1679-18-1

4-Chlorophenylboronic acid

benzaldehyde
100-52-7

benzaldehyde

5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

4-(4-chlorophenyl)-6-iodo-2-phenylquinazoline

4-(4-chlorophenyl)-6-iodo-2-phenylquinazoline

Conditions
ConditionsYield
With potassium fluoride; 5,5'-dimethyl-2,2'-bipyridine; bis(acetylacetonato)palladium(II); trifluorormethanesulfonic acid In N,N-dimethyl-formamide at 80℃; for 48h; Sealed tube; Schlenk technique;65%
5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

2-naphthylmethylzinc chloride

2-naphthylmethylzinc chloride

2-amino-5-(2'-naphthylmethyl)benzonitrile
378791-67-4

2-amino-5-(2'-naphthylmethyl)benzonitrile

Conditions
ConditionsYield
dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2 In tetrahydrofuran for 0.5h; Heating;63%
5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

(2-chlorobenzyl)zinc(II) chloride
312624-11-6

(2-chlorobenzyl)zinc(II) chloride

2-amino-5-(2'-chlorobenzyl)benzonitrile
378791-55-0

2-amino-5-(2'-chlorobenzyl)benzonitrile

Conditions
ConditionsYield
dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2 In tetrahydrofuran for 0.5h; Heating;62%
5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

(2-methoxybenzyl)zinc(II) chloride
312693-15-5

(2-methoxybenzyl)zinc(II) chloride

2-amino-5-(2'-methoxybenzyl)benzonitrile
378791-60-7

2-amino-5-(2'-methoxybenzyl)benzonitrile

Conditions
ConditionsYield
dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2 In tetrahydrofuran for 0.5h; Heating;61%
4-methylphenylboronic acid
5720-05-8

4-methylphenylboronic acid

benzaldehyde
100-52-7

benzaldehyde

5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

6-iodo-2-phenyl-4-(p-tolyl)quinazoline

6-iodo-2-phenyl-4-(p-tolyl)quinazoline

Conditions
ConditionsYield
With potassium fluoride; 5,5'-dimethyl-2,2'-bipyridine; bis(acetylacetonato)palladium(II); trifluorormethanesulfonic acid In N,N-dimethyl-formamide at 80℃; for 48h; Sealed tube; Schlenk technique;61%
5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

(4-chlorobenzyl)zinc(II) chloride

(4-chlorobenzyl)zinc(II) chloride

2-amino-5-(4'-chlorobenzyl)benzonitrile

2-amino-5-(4'-chlorobenzyl)benzonitrile

Conditions
ConditionsYield
dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2 In tetrahydrofuran for 0.5h; Heating;59%
5-iodoanthranilonitrile
132131-24-9

5-iodoanthranilonitrile

3,5-dimethoxybenzylzinc chloride

3,5-dimethoxybenzylzinc chloride

2-amino-5-(3',5'-dimethoxybenzyl)benzonitrile

2-amino-5-(3',5'-dimethoxybenzyl)benzonitrile

Conditions
ConditionsYield
dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2 In tetrahydrofuran for 0.5h; Heating;59%

132131-24-9Relevant articles and documents

Synthesis of 7-[123I]idotacrine: A potential SPECT agent to map acetylcholinesterase

Akula, Murthy R.,Kabalka, George W.

, p. 959 - 964 (1999)

9-Amino-1,2,3,4-tetrahydroacridine (Tacrine), a cognitive enhancer, is an inhibitor of the enzyme acetylcholinesterase. The synthesis of no-carrier-added 7-[123I]iodotacrine, was accomplished in four steps for potential use in mapping acetylcholinesterase.

2-Cyano-4-iodo-acetanilide: A hydrogen-bonded chain of R 2 2(12) and R22(14) rings

Garden, Simon J.,Custodio, Cintia De A.,Wardell, James L.,Low, John N.,Glidewell, Christopher

, p. o408-o410 (2007)

The mol-ecules of 2-cyano-4-iodo-acetanilide, C9H7IN2O, are linked by N - H...N and C - H...O hydrogen bonds into chains of alternating R 2 2(12) and R 2 2(14) rings. International Union of Crystallography 2007.

Novel 4-arylaminoquinazolines bearing N,N-diethyl(aminoethyl)amino moiety with antitumour activity as EGFRwt-TK inhibitor

Zhang, Yaling,Chen, Li,Li, Xiabing,Gao, Li,Hao, Yunxia,Li, Baolin,Yan, Yaping

, p. 1668 - 1677 (2019/10/14)

Herein, four novel 4-arylaminoquinazoline derivatives with N,N-diethyl(aminoethyl)amino moiety were designed, synthesised and evaluated on biological activities in vitro. All synthesised compounds have inhibitory effects against tumour cells (SW480, A549, A431 and NCI-H1975). In particular, 4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-6-(5-((N,N-diethyl(aminoethyl))aminomethyl)furan-2-yl)quinazoline (6a) and 6-(5-((N,N-diethylethyl)aminomethyl)furan-2-yl)-4-(4-(E)-(propen-1-yl)phenylamino)quinazoline (6d) were potent antitumour agents which showed high antiproliferative activities against tumour cells in vitro. Moreover, compound 6a could induce late apoptosis of A549 cells at high concentrations and arrest cell cycle of A549 cells in the G0/G1 phase at tested concentrations. Also, compound 6a could inhibit the activity of wild type epidermal growth factor receptor tyrosine kinase (EGFRwt-TK) with IC50 value of 15.60 nM. Molecular docking showed that compound 6a formed three hydrogen bonds with EGFRwt-TK, while lapatinib formed only two hydrogen bonds with the receptor protein. It is believed that this work would be giving a reference for developing anti-cancer drugs targeted EGFR-TK.

Lapatinib intermediate and its preparation method and application

-

Paragraph 0041-0043, (2016/10/09)

The invention discloses a lapatinib intermediate as well as a preparation method and application thereof. The lapatinib intermediate contains chemical structures respectively shown in a formula IV, a formula V and a formula VIII (described in the specification). The lapatinib intermediate provided by the invention has the advantages of simple preparation technology, available raw materials, mild reaction conditions, high yield, easy control on quality and the like; by applying the lapatinib intermediate, a preparation route of lapatinib can be shortened, operation is simple, reaction conditions are mild, especially adoption of poisonous reagents such as sulfoxide chloride and phosphorus oxychloride can be avoided, the lapatinib intermediate can be stable in each step, post treatment is simple, yield is high, the lapatinib intermediate is applicable to mass production and has practical value, and large-scale industrial production demand of lapatinib can be met.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 132131-24-9